Article

First ophthalmology training center opens in Indonesia

Bandung, Indonesia-Micheal Kaschke, PhD, director of Carl Zeiss AG and chairman of the supervisory board of Carl Zeiss Meditec AG, opened the first training center for ophthalmology at the Cicendo Hospital in Bandung, Indonesia as a part of the Vision 2020 Initiative to eliminate avoidable blindness by 2020.

Bandung, Indonesia-Micheal Kaschke, PhD, director of Carl Zeiss AG and chairman of the supervisory board of Carl Zeiss Meditec AG, opened the first training center for ophthalmology at the Cicendo Hospital in Bandung, Indonesia as a part of the Vision 2020 Initiative to eliminate avoidable blindness by 2020.

With the help of Gullapalli N. Rao, MD, president of the International Agency for the Prevention of Blindness and representative of the Indonesian government, the goal is to eventually make high-quality eye treatment available and affordable to millions of people, according to Dr. Kasche.

Keeping in mind the population size, extent, and gravity of eye diseases; existing training programs; and available resources, this relief organization selected Indonesia as the location for this eye center. There are 600 eye specialists and 2,200 qualified medium-level medical personnel.

 Approximately 40,000 cataract operations are performed each year.

The $200,000 donation from Carl Zeiss will be used for training staff and equipment. Some other donations included several systems for diagnosis, treatment, and aftercare, including slit lamps, treatment lasers, and a surgical microscope. Carl Zeiss will be supporting training centers in five regions within the next 5 years.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
Wendy Lee, MD, MS, at Controversies in Modern Eye Care 2025.
© 2025 MJH Life Sciences

All rights reserved.